Interaction of carbamazepine with herbs, dietary supplements, and food: A systematic review

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Fong, Sophia Yui Kau ^a   Gao, Qiong ^a   Zuo, Zhong ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACORUS CALAMUS EXTRACT; ALCOHOL; BERBERINE; BR 16A; CAFFEINE; CARBAMAZEPINE; CARDIOSPERMUM HALICACABUM EXTRACT; CHAI HU JIALONG GU MU LI TANG; CHINESE DRUG; FOLINIC ACID; GINKGO BILOBA EXTRACT; GINSENOSIDE; HERBACEOUS AGENT; HU GAN NING PIAN; HYPERICUM PERFORATUM EXTRACT; ISPAGULA; JIA WEI XIAO YAO SAN; MELATONIN; NICOTINAMIDE; PAEONIA RADIX; PIPERINE; PLATYCODONIS RADIX EXTRACT; POLYGONUM CUSPIDATUM EXTRACT; SEPTILIN; SHO SEIRYU TO; UNCLASSIFIED DRUG; UNINDEXED DRUG; XIAO CHA HU TANG; XIAO CHAHU TANG; XIAO YAO SAN;

ACORUS CALAMUS; ADVERSE OUTCOME; ANTICONVULSANT ACTIVITY; BLURRED VISION; CARDIOSPERMUM HALICACABUM; CINAHL; COCHRANE LIBRARY; DIET SUPPLEMENTATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; EMBASE; FOOD; FOOD DRUG INTERACTION; GINKGO BILOBA; GINSENG; GRAPEFRUIT JUICE; HEALTH CARE PERSONNEL; HERB; HERB DRUG INTERACTION; HERBAL MEDICINE; HONEY; HUMAN; NAUSEA; NONHUMAN; PIPER LONGUM; PLATYCODONIS RADIX; POLYGONUM CUSPIDATUM; PRESCRIPTION; PRIORITY JOURNAL; RASH; REFERENCE DATABASE; REVIEW; SCIFINDER SCHOLAR; SENNA AURICULATA; TREATMENT OUTCOME;

EID: 84884276455     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/898261     Document Type: Review

References (81)

1. Moran N. F., Poole K., Bell G., Solomon J., Kendall S., McCarthy M., McCormick D., Nashef L., Sander J., Shorvon S. D., Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 2004 13 6 425 433 2-s2.0-19244366534 10.1016/j.seizure.2003.10.002
2. Hsieh L. P., Huang C. Y., Antiepileptic drug utilization in Taiwan: analysis of prescription using national health insurance database. Epilepsy Research 2009 84 1 21 27 2-s2.0-60949096315 10.1016/j.eplepsyres.2008.11.018
3. Bielen I., Sruk A., Planjar-Prvan M., Cvitanović-Šojat L., Košiček M., Bergman-Marković B., Baraba R., Butković-Soldo S., Age-related pattern of the antiepileptic drug utilization in active epilepsy: a population-based survey. Collegium Antropologicum 2009 33 2 659 663 2-s2.0-70149120377
4. Ishihara-Paul L., Webb D. J., Irizarry M., Weil J., Exploring differential prescribing between anti-epileptic drugs in epilepsy patients with a history of mood disorders. Pharmacoepidemiology and Drug Safety 2010 19 3 289 295 2-s2.0-77649226950 10.1002/pds.1905
5. Lowenstein D., Braunwald E., Hauser S., Fauci A. S., Longo D. H., Kasper D. L., Seizures and epilepsy. Harrison's Principle of Internal Medicine 2005 New Delhi, India McGraw-Hill Medical Publishing 2359 2369
6. Barry E., William R. G., DiPiro J. T., Talbert R., Yee C. G., Matzke G. R., Wells G. B., Posey L. M., Epilepsy. Pharmacotherapy: A Pathophysiologic Approach 2006 New Delhi, India McGraw-Hill Medical Publishing 1023 1074
7. Ketter T. A., Post R. M., Worthington K., Principles of clinically important drug interactions with carbamazepine. Part I. Journal of Clinical Psychopharmacology 1991 11 3 198 203 2-s2.0-0025891705
8. Kane G. C., Lipsky J. J., Drug-grapefruit juice interactions. Mayo Clinic Proceedings 2000 75 9 933 942 2-s2.0-0033831256
9. Potter J. M., Donnelly A., Carbamazepine-10,11-epoxide in therapeutic drug monitoring. Therapeutic Drug Monitoring 1998 20 6 652 657 2-s2.0-0031785952 10.1097/00007691-199812000-00012
10. So E. L., Ruggles K. H., Cascino G. D., Ahmann P. A., Weatherford K. W., Seizure exacerbation and status epilepticus related to carbamazepine-10,11- epoxide. Annals of Neurology 1994 35 6 743 746 2-s2.0-0028260671 10.1002/ana.410350616
11. Bialer M., Levy R. H., Perucca E., Does carbamazepine have a narrow therapeutic plasma concentration range? Therapeutic Drug Monitoring 1998 20 1 56 59 2-s2.0-0031935126 10.1097/00007691-199802000-00010
12. Bissery M. C., Vrignaud P., Lavelle F., Chabot G. G., Preclinical antitumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing mice. Annals of the New York Academy of Sciences 1996 803 173 180 2-s2.0-0030452954 10.1111/j.1749-6632.1996.tb26386.x
13. Pellock J. M., Carbamazepine side effects in children and adults. Epilepsia 1987 28 3 S64 S70 2-s2.0-0023611675
14. Fisher R. S., Cysyk B., A fatal overdose of carbamazepine: case report and review of literature. Journal of Toxicology-Clinical Toxicology 1988 26 7 477 486 2-s2.0-0024274466
15. Durelli L., Massazza U., Cavallo R., Carbamazepine toxicity and poisoning: incidence, clinical features and management. Medical Toxicology and Adverse Drug Experience 1989 4 2 95 107 2-s2.0-0024536434
16. Vietri M., Pietrabissa A., Mosca F., Pacifici G. M., Mycophenolic acid glucuronidation and its inhibition by non-steroidal anti-inflammatory drugs in human liver and kidney. European Journal of Clinical Pharmacology 2000 56 9-10 659 664 2-s2.0-0034467567 10.1007/s002280000227
17. Herber R., Magdalou J., Haumont M., Bidault R., van Es H., Siest G., Glucuronidation of 3′-azido-3′-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones. Biochimica et Biophysica Acta 1992 1139 1-2 20 24 2-s2.0-0026655104 10.1016/0925-4439(92) 90077-Z
18. Miners J. O., Lillywhite K. J., Assessment of the drug inhibitor specificity of the human liver 4-methylumbelliferone UDP-glucuronosyltransferase activity. Biochemical Pharmacology 1991 41 5 838 841 2-s2.0-0026031678 10.1016/0006-2952(91)90090-R
19. Kaneda N., Nagata H., Furuta T., Yokokura T., Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse. Cancer Research 1990 50 6 1715 1720 2-s2.0-0025272187
20. Von Hoff D. D., Burris H. A. III, Eckardt J., Rothenberg M., Fields S. M., Chen-S. F., Kuhn J. G., Preclinical and phase I trials of topoisomerase I inhibitors. Cancer Chemotherapy and Pharmacology 1994 34, supplement S41 S45 2-s2.0-0028024504
21. Mohamed M. F., Frye R. F., Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. Planta Medica 2011 77 4 311 321 2-s2.0-79952479196 10.1055/s-0030-1250457
22. Chen L. C., Chen Y. F., Yang L. L., Chou M. H., Lin M. F., Drug utilization pattern of antiepileptic drugs and traditional Chinese medicines in a general hospital in Taiwan-a pharmaco-epidemiologic study. Journal of Clinical Pharmacy and Therapeutics 2000 25 2 125 129 2-s2.0-0034068845 10.1046/j.1365-2710.2000.00271.x
23. Easterford K., Clough P., Comish S., Lawton L., Duncan S., The use of complementary medicines and alternative practitioners in a cohort of patients with epilepsy. Epilepsy and Behavior 2005 6 1 59 62 2-s2.0-12144259299 10.1016/j.yebeh.2004.10.007
24. Liow K., Ablah E., Nguyen J. C., Sadler T., Wolfe D., Tran K., Guo L., Hoang T., Pattern and frequency of use of complementary and alternative medicine among patients with epilepsy in the midwestern United States. Epilepsy and Behavior 2007 10 4 576 582 2-s2.0-34249043248 10.1016/j.yebeh.2007.02.017
25. Bhalla D., Chea K., Hun C., Vannareth M., Huc P., Chan S., Sebbag R., Gérard D., Dumas M., Oum S., Druet-Cabanac M., Preux P. M., Population-based study of epilepsy in Cambodia associated factors, measures of impact, stigma, quality of life, knowledge-attitude-practice, and treatment gap. PLoS ONE 2012 7 10 e46296 10.1371/journal.pone.0046296
26. Tandon M., Prabhakar S., Pandhi P., Pattern of use of complementary/alternative medicine (CAM) in epileptic patients in a tertiary care hospital in India. Pharmacoepidemiology and Drug Safety 2002 11 6 457 463 2-s2.0-0036750746 10.1002/pds.731
27. Danesi M. A., Adetunji J. B., Use of alternative medicine by patients with epilepsy: a survey of 265 epileptic patients in a developing country. Epilepsia 1994 35 2 344 351 2-s2.0-0028220895
28. White S. D., Deciphering "integrated Chinese and Western medicine" in the rural Lijiang basin: state policy and local practice(s) in socialist China. Social Science and Medicine 1999 49 10 1333 1347 2-s2.0-0033231729 10.1016/S0277-9536(99)00176-8
29. Howard N., Tsourounis C., Kapusnik-Uner J., Dietary supplement survey of pharmacists: personal and professional practices. Journal of Alternative and Complementary Medicine 2001 7 6 667 680 2-s2.0-0035689502
30. Ioannides C., Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 2002 32 6 451 478 2-s2.0-0036304016 10.1080/00498250210124147
31. Hu Z., Yang X., Ho P. C. L., Sui Y. C., Heng P. W. S., Chan E., Duan W., Hwee L. K., Zhou S., Herb-drug interactions: a literature review. Drugs 2005 65 9 1239 1282 2-s2.0-22844441147 10.2165/00003495-200565090-00005
32. Tsai H. H., Lin H. W., Pickard A. S., Tsai H. Y., Mahady G. B., Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012 66 11 1056 1078 10.1111/j.1742-1241.2012. 03008.x
33. Mills E., Wu P., Johnston B. C., Gallicano K., Clarke M., Guyatt G., Natural health product-drug interactions: a systematic review of clinical trials. Therapeutic Drug Monitoring 2005 27 5 549 557 2-s2.0-26444461625 10.1097/01.ftd.0000170880.95267.90
34. Samuels N., Finkelstein Y., Singer S. R., Oberbaum M., Herbal medicine and epilepsy: proconvulsive effects and interactions with antiepileptic drugs. Epilepsia 2008 49 3 373 380 2-s2.0-39749187373 10.1111/j.1528-1167.2007.01379.x
35. Katyal J., Sarangal V., Gupta Y. K., Interaction of hydroalcoholic extract of Acorus calamus Linn. with sodium valproate and carbamazepine. Indian Journal of Experimental Biology 2012 50 1 51 55 2-s2.0-84855278495
36. Qiu W., Jiang X. H., Liu C. X., Ju Y., Jin J. X., Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytotherapy Research 2009 23 11 1553 1558 2-s2.0-70350437674 10.1002/ptr.2808
37. Thabrew I., Munasinghe J., Chackrewarthi S., Senarath S., The effects of Cassia auriculata and Cardiospermum halicacabum teas on the steady state blood level and toxicity of carbamazepine. Journal of Ethnopharmacology 2004 90 1 145 150 2-s2.0-0346492906 10.1016/j.jep.2003.09.040
38. Ohnishi N., Nakasako S., Okada K., Umehara S., Takara K., Nagasawa K., Yoshioka M., Kuroda K., Yokoyama T., Studies on interactions between traditional herbal and western medicines. IV: lack of pharmacokinetic interactions between saiko-ka-ryukotsu-borei-to and carbamazepine in rats. European Journal of Drug Metabolism and Pharmacokinetics 2001 26 1-2 129 135 2-s2.0-0034878824
39. Haop M., Zhao Y., Chen P., Huang H., Liu H., Jiang H., Zhang R., Wang H., Structure-activity relationship and substrate-depedent phenomena in effects of ginsenosides on activities of drug-metabolizing P450 enzymes. PLoS ONE 2008 3 7 2-s2.0-49949113587 10.1371/journal.pone.0002697 e2697
40. Chandra R. H., Rajkumar M., Veeresham C., Pharmacokinetic interaction of ginkgo biloba with carbamazepine. Planta Medica 2009 4 454. Proceedings of the 8th Annual Oxford International Conference on the Science of Botanicals University
41. Zheng Y., Yang C. Q., Zhang C. H., Effect of huganning tablets on pharmacokinetics of carbamazepine in rats. Chinese Journal of Pharmaceuticals 2009 40 2 117 119
42. Burstein A. H., Horton R. L., Dunn T., Alfaro R. M., Piscitelli S. C., Theodore W., Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers. Clinical Pharmacology and Therapeutics 2000 68 6 605 612 2-s2.0-0034525583 10.1067/mcp.2000.111530
43. Etman M. A., Effect of a bulk forming laxative on the bioavailability of carbamazepine in man. Drug Development and Industrial Pharmacy 1995 21 16 1901 1906 2-s2.0-0029081909
44. Zhang Z. J., Kang W. H., Li Q., Tan Q., The beneficial effects of the herbal medicine free and easy wanderer plus (FEWP) for mood disorders: double-blind, placebo-controlled studies. Journal of Psychiatric Research 2007 41 10 828 836 2-s2.0-34247891715 10.1016/j.jpsychires.2006.08.002
45. Tripathi M., Sundaram R., Rafiq M., Venkataranganna M. V., Gopumadhavan S., Mitra S. K., Pharmacokinetic interactions of Mentat with carbamazepine and phenytoin. European Journal of Drug Metabolism and Pharmacokinetics 2000 25 3-4 223 226 2-s2.0-0034440161
46. Chen L. C., Chen Y. F., Chou M. H., Lin M., Yang L., Yen K., Pharmacokinetic interactions between carbamazepine and the traditional Chinese medicine Paeoniae Radix. Biological and Pharmaceutical Bulletin 2002 25 4 532 535 2-s2.0-0036545411 10.1248/bpb.25.532
47. Pattanaik S., Hota D., Prabhakar S., Kharbanda P., Pandhi P., Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytotherapy Research 2009 23 9 1281 1286 2-s2.0-69749121899 10.1002/ptr.2676
48. Liu P., Wei L., Effect of Platycodon grandiflorum on the blood concentration of carbamazepine in rabbits. Evaluation and Analysis of Drug-Use in Hospitals of China 2008 8 5
49. Chi Y. C., Lin S. P., Hou Y. C., A new herb-drug interaction of Polygonum cuspidatum, a resveratrol-rich nutraceutical, with carbamazepine in rats. Toxicology and Applied Pharmacology 2012 263 3 315 322 10.1016/j.taap.2012.07. 003
50. Garg S. K., Islam A. S., Kumar N., Effect of septilin-a herbal preparation on pharmacokinetics of carbamazepine in rabbits. Indian Journal of Physiology and Pharmacology 1998 42 4 527 532 2-s2.0-0031736045
51. Ohnishi N., Okada K., Yoshioka M., Kuroda K., Nagasawa K., Takara K., Yokoyama T., Studies on interactions between traditional herbal and western medicines. V. Effects of Sho-saiko-to (Xiao-Cai-hu-Tang) on the pharmacokinetics of carbamazepine in rats. Biological and Pharmaceutical Bulletin 2002 25 11 1461 1466 2-s2.0-0344722518 10.1248/bpb.25.1461
52. Ohnishi N., Yonekawa Y., Nakasako S., Nagasawa K., Yokoyama T., Yoshioka M., Kuroda K., Studies on interactions between traditional herbal and western medicines. I. Effects of Sho-seiryu-to on the pharmacokinetics of carbamazepine in rats. Biological and Pharmaceutical Bulletin 1999 22 5 527 531 2-s2.0-0033020410
53. Li W. K. Q., Tan Q., Zhang Z., Randomized double-blind controlled clinical trial of the combination of Xiao-yao-san and carbamazepine in the treatment of bipolar disorders. Zhong Guo Lin Chuang Yao Li Xue Za Zhi 2005 21 336 340
54. Dar M. S., Hardee M., Ganey T., Brain adenosine modulation of behavioral interactions between ethanol and carbamazepine in mice. Alcohol 1989 6 4 297 301 2-s2.0-0024418677
55. Sternebring B., Lidén A., Andersson K., Melander A., Carbamazepine kinetics and adverse effects during and after ethanol exposure in alcoholics and in healthy volunteers. European Journal of Clinical Pharmacology 1992 43 4 393 397 2-s2.0-0026758502 10.1007/BF02220615
56. Sidhu S., Malhotra S., Garg S. K., Influence of high fat diet (butter) on the pharmacokinetics of phenytoin and carbamazepine. Methods and Findings in Experimental and Clinical Pharmacology 2004 26 8 635 638 2-s2.0-16644399987
57. Vaz J., Kulkarni C., David J., Joseph T., Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers. Indian Journal of Experimental Biology 1998 36 1 112 114 2-s2.0-0031951118
58. Czuczwar S. J., Gasior M., Janusz W., Szczepanik B., Wlodarczyk D., Kleinrok Z., Influence of different methylxanthines on the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia 1990 31 3 318 323 2-s2.0-0025353385
59. Gasior M., Borowicz K., Kleinrok Z. X., Czuczwar S. J., Chronic caffeine and the anticonvulsant potency of antiepileptic drugs against maximal electroshock. Pharmacology Biochemistry and Behavior 1996 54 4 639 644 2-s2.0-0030217883 10.1016/0091-3057(95)02222-8
60. Malhotra S., Dixit R. K., Garg S. K., Effect of an acidic beverage (Coca-Cola) on the pharmacokinetics of carbamazepine in healthy volunteers. Methods and Findings in Experimental and Clinical Pharmacology 2002 24 1 31 33 2-s2.0-0036199508 10.1358/mf.2002.24.1.677125
61. Smith D. B., Carl G. F., Interactions between folates and carbamazepine or valproate in the rat. Neurology 1982 32 9 965 969 2-s2.0-0019943881
62. Garg S. K., Kumar N., Bhargava V. K., Prabhakar S. K., Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clinical Pharmacology and Therapeutics 1998 64 3 286 288 2-s2.0-0031657386 10.1016/S0009-9236(98)90177-1
63. Koumaravelou K., Adithan C., Shashindran C. H., Asad M., Abraham B. K., Effect of honey on carbamazepine kinetics in rabbits. Indian Journal of Experimental Biology 2002 40 5 560 563 2-s2.0-0036013720
64. Malhotra S., Garg S. K., Dixit R. K., Effect of concomitantly administered honey on the pharmacokinetics of carbamazepine in healthy volunteers. Methods and Findings in Experimental and Clinical Pharmacology 2003 25 7 537 540 2-s2.0-0142027048 10.1358/mf.2003.25.7.778093
65. Thomas V., Ramasamy K., Sundaram R., Chandrasekaran A., Effect of honey on CYP3A4 enzyme and P-glycoprotein activity in healthy human volunteers. Iranian Journal of Pharmacology and Therapeutics 2007 6 2 171 176 2-s2.0-55949085571
66. Garg S. K., Bhargava V. K., James H., Kumar N., Prabhakar S., Influence of kinnow juice on the bioavailability of carbamazepine in healthy male volunteers. Neurology India 1998 46 3 229 231 2-s2.0-0032470247
67. Borowicz K. K., Kamiński R., Gasior M., Kleinrok Z., Czuczwar S. J., Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. European Neuropsychopharmacology 1999 9 3 185 190 2-s2.0-0345435108 10.1016/S0924- 977X(98)00022-4
68. Gupta M., Gupta Y. K., Agarwal S., Aneja S., Kalaivani M., Kohli K., Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial. Epilepsia 2004 45 12 1636 1639 2-s2.0-10644278744 10.1111/j.0013-9580.2004.17604.x
69. Gupta Y. K., Gupta M., Chaudhary G., Kohli K., Modulation of antiepileptic effect of phenytoin and carbamazepine by melatonin in mice. Methods and Findings in Experimental and Clinical Pharmacology 2004 26 2 99 102 2-s2.0-1842555453 10.1358/mf.2004.26.2.800061
70. Said H. M., Redha R., Nylander W., Biotin transport in the human intestine: inhibition by anticonvulsant drugs. The American Journal of Clinical Nutrition 1989 49 1 127 131 2-s2.0-0024592362
71. Hidaka M., Okumura M., Fujita K., Ogikubo T., Yamasaki K., Iwakiri T., Setoguchi N., Arimori K., Effects of pomegranate juice on human cytochrome P450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metabolism and Disposition 2005 33 5 644 648 2-s2.0-17844399522 10.1124/dmd.104.002824
72. Adukondalu D., Kumar Y. S., Vishnu Y. V., Kumar R. S., Rao Y. M., Effect of pomegranate juice pre-treatment on the transport of carbamazepine across rat intestine. DARU, Journal of Pharmaceutical Sciences 2010 18 4 254 259 2-s2.0-79251518928
73. Singh D., Asad M., Effect of soybean administration on the pharmacokinetics of carbamazepine and omeprazole in rats. Fundamental and Clinical Pharmacology 2010 24 3 351 355 2-s2.0-77952575634 10.1111/j.1472-8206. 2009.00762.x
74. Hidaka M., Okumura M., Ogikubo T., Kai H., Fujita K., Iwakiri T., Yamasaki K., Setoguchi N., Matsunaga N., Arimori K., Transient inhibition of CYP3A in rats by star fruit juice. Drug Metabolism and Disposition 2006 34 3 343 345 2-s2.0-33344468481 10.1124/dmd.105.006486
75. Spina E., Pisani F., Perucca E., Clinically significant pharmacokinetic drug interactions with carbamazepine. Clinical Pharmacokinetics 1996 31 3 198 214 2-s2.0-0029815563
76. Perucca E., Clinically relevant drug interactions with antiepileptic drugs. The British Journal of Clinical Pharmacology 2006 61 3 246 255 2-s2.0-33644909875 10.1111/j.1365-2125.2005.02529.x
77. Wong Y. C., Qian S., Zuo Z., Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions. Expert Opinion on Drug Metabolism and Toxicology 2012 8 7 833 854 10.1517/17425255.2012.688027
78. Warner T., Patsalos P. N., Prevett M., Elyas A. A., Duncan J. S., Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11-epoxide. Epilepsy Research 1992 11 2 147 150 2-s2.0-0026597799 10.1016/0920-1211(92)90049-Y
79. Pitterle M. E., Collins D. M., Carbamazepine-10-11-epoxide evaluation associated with coadministration of loxapine or amoxapine. Epilepsia 1988 29 article 654
80. Jolivette L. J., Ward K. W., Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: molecular properties associated with extrapolative success or failure. Journal of Pharmaceutical Sciences 2005 94 7 1467 1483 2-s2.0-23844500635 10.1002/jps.20373
81. Vocci F., Farber T., Extrapolation of animal toxicity data to man. Regulatory Toxicology and Pharmacology 1988 8 4 389 398 2-s2.0-0024227409